Risk Factors for Rectal Cancer Recurrence after Local Excision of T1 Lesions from a Decade-Long Multicenter Retrospective Study

被引:0
|
作者
Rudnicki, Yaron [1 ]
Goldberg, Nitzan [1 ]
Horesh, Nir [2 ]
Harbi, Assaf [3 ]
Lubianiker, Barak [4 ]
Green, Eraan [5 ]
Raveh, Guy [6 ]
Slavin, Moran [1 ]
Segev, Lior [2 ]
Gilshtein, Haim [3 ]
Barenboim, Alexander [5 ]
Wasserberg, Nir [6 ]
Khaikin, Marat [2 ]
Tulchinsky, Hagit [5 ]
Issa, Nidal [4 ]
Duek, Daniel [3 ]
Avital, Shmuel [1 ]
White, Ian [6 ]
机构
[1] Tel Aviv Univ, Fac Med, Meir Med Ctr, Dept Surg, IL-6997801 Tel Aviv, Israel
[2] Tel Aviv Univ, Fac Med, Sheba Med Ctr, Dept Gen Surg & Organ Transplantat B, IL-6997801 Tel Aviv, Israel
[3] Technion Israel Inst Technol, Rappaport Fac Med, Dept Gen Surg, Rambam Hlth Care Campus, IL-3109601 Haifa, Israel
[4] Tel Aviv Univ, Hasharon Hosp, Fac Med, Rabin Med Ctr,Dept Surg, IL-6997801 Tel Aviv, Israel
[5] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Surg, IL-6997801 Tel Aviv, Israel
[6] Tel Aviv Univ, Beilinson Hosp, Fac Med, Rabin Med Ctr,Dept Surg, IL-6997801 Tel Aviv, Israel
关键词
early rectal cancer; t1 rectal cancer; local excision; rectal cancer recurrence; TRANSANAL ENDOSCOPIC MICROSURGERY; TERM SURVIVAL;
D O I
10.3390/jcm13144139
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Local surgical excision of T1 rectal adenocarcinoma is a well-established approach. Yet, there are still open questions regarding the recurrence rates and its risk factors. Methods: A retrospective multicenter study including all patients who underwent local excision of early rectal cancer with an open or MIS approach and had a T1 lesion from 2010 to 2020 in six academic centers. Data included demographics, preoperative studies, surgical findings, postoperative outcomes, and local and systemic recurrence. A univariable and multivariable logistic regression analysis was performed to identify risk factors for recurrence. Results: Overall, 274 patients underwent local excision of rectal lesions. Of them, 97 (35.4%) patients with a T1 lesion were included in the cohort. The mean age was 69 +/- 10.5 years, and 42 (43.3%) were female. The mean distance of the lesions from the anal verge was 7.8 +/- 3.2 cm, and the average tumor size was 2.7 +/- 1.6 cm. Eighty-two patients (85%) had a full-thickness resection. Eight patients (8%) had postoperative complications. Kikuchi classification of submucosal (SM) involvement was reported in 29 (30%) patients. Twelve patients had SM1, two SM2, and fifteen SM3. Following pathology, 24 patients (24.7%) returned for additional surgery or treatment. The overall recurrence rate was 14.4% (14 patients), with 11 patients having a local recurrence and 6 having a systemic metastatic recurrence, 3 of which had both. The mean time for recurrence was 2.78 +/- 2.8 years and the overall mortality rate was 11%. On univariable and multivariable logistic regression analysis of recurrence vs. non-recurrence groups, the strongest and most significant association and possible risk factors for recurrence were larger lesions (4.3 vs. 2.5 cm, p < 0.001) with an OR of 6.67 (CI-1.82-24.36), especially for tumors larger than 3.5 cm, mucinous histology (14.3% vs. 1.2%, p = 0.004, OR of 14.02, CI-1.13-173.85), and involved margins (41.7% vs. 16.2%, p = 0.003, OR of 9.59, CI-2.14-43.07). The open transanal excision (TAE) approach was also identified as a possible significant risk factor in univariant analysis, while SM3 level penetration showed only a trend. Conclusion: Surgical local excision of T1 rectal malignancy is a safe and viable option. Still, one in four patients received additional treatment. There is an almost 15% chance for recurrence, especially in large tumors, mucinous histology, or involved margin cases. These high-risk patients might warrant additional intervention and stricter surveillance protocols.
引用
收藏
页数:10
相关论文
共 44 条
  • [41] Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
    Hughes, R
    Glynne-Jones, R
    Grainger, J
    Richman, P
    Makris, A
    Harrison, M
    Ashford, R
    Harrison, RA
    Livingstone, JI
    McDonald, PJ
    Thomas, JM
    Mitchell, IC
    Northover, JMA
    Phillips, R
    Wallace, M
    Windsor, A
    Novell, JR
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2006, 21 (01) : 11 - 17
  • [42] Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3–T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
    R. Hughes
    R. Glynne-Jones
    J. Grainger
    P. Richman
    A. Makris
    M. Harrison
    R. Ashford
    R. A. Harrison
    J. I. Livingstone
    P. J. McDonald
    J. Meyrick Thomas
    I. C. Mitchell
    J. M. A. Northover
    R. Phillips
    M. Wallace
    A. Windsor
    J. R. Novell
    International Journal of Colorectal Disease, 2006, 21 : 11 - 17
  • [43] Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2-T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)
    Serra-Aracil, X.
    Pericay, C.
    Golda, T.
    Mora, L.
    Targarona, E.
    Delgado, S.
    Reina, A.
    Vallribera, F.
    Enriquez-Navascues, J. M.
    Serra-Pla, S.
    Garcia-Pacheco, J. C.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2018, 33 (02) : 241 - 249
  • [44] Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens - Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision
    Goldstein, NS
    Hart, J
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 111 (01) : 51 - 58